Global Companion Diagnostics Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The Companion Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Companion Diagnostics Market Size Expected to Be by 2034?
Over the past several years, the size of the companion diagnostics market has seen a swift expansion. It's set to rise from $7.34 billion in 2024 to $8.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 19.3%. Factors contributing to this growth during the historic period include a greater uptake of personalized medicine, developments in oncology and cancer therapies, a boost in pharmaceutical research and development collaboration, initiatives in precision medicine, and the discovery of biomarkers.

The size of the companion diagnostics market is anticipated to witness remarkable growth in the upcoming years, reaching a value of $19.07 billion in 2029, with a CAGR of 21.5%. This significant surge during the forecast period can be credited to factors such as the advancement of targeted therapy, the rise of infectious disease diagnostics, increased diagnostics for rare diseases, heightened development of biomarker-based drugs, the growth of point-of-care testing, and liquid biopsy applications. Additionally, the introduction of techniques such as artificial intelligence and machine learning in diagnostics, product innovations, the integration of Industry 4.0, and strategic partnerships represent key trends for the forecast period.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7038

What Are the Emerging Segments Within the Companion Diagnostics Market?
The companion diagnostics market covered in this report is segmented -

1) By Product And Service: Assays, Kits And Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry
3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations

Subsegments:
1) By Assays: Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays
2) By Kits And Reagents: Diagnostic Kits, Detection Reagents, Control Reagents
3) By Software And Services: Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7038&type=smp

What Long-Term Drivers Are Shaping Companion Diagnostics Market Trends?
The growth of the companion diagnostics market is anticipated to be driven by the rising prevalence of targeted therapies. Specific characteristics of cancer cells are the focus of targeted therapy, a pharmacological treatment designed to prevent the disease's expansion and proliferation. While the drugs are dispersed throughout the body, they typically have a more focussed impact than chemotherapy and often result in fewer negative effects. Companion diagnostic testing for targeted cancer treatment based on biological markers is becoming increasingly crucial in personalized cancer treatment. For example, the Personalised Medicine Coalition, a healthcare and hospital organization from the US, reported in February 2024 that the FDA approved 16 novel personalized treatments for patients with rare diseases in 2023, an increase from just six in 2022. Hence, the boost in targeted therapies stimulates progress in the companion diagnostics market.

Who Are the Top Competitors in Key Companion Diagnostics Market Segments?
Major companies operating in the companion diagnostics market include F Hoffmann-La Roche Ltd., Agilent Technologies Inc., Qiagen NV, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Abnova Corp., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, Biomerieux SA, Danaher Corporation, Guardant Health Inc., Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Caris Life Sciences, Cepheid Inc., Diaceutics plc, Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Precision Therapeutics Inc., Prometheus Laboratories Inc., Sividon Diagnostics GmbH, Sysmex Corporation, Ventana Medical Systems, Vermillion Inc.

What Companion Diagnostics Market Trends Are Gaining Traction Across Different Segments?
Advancements in technology is a major trend in the market of companion diagnostics. Artificial intelligence plays a pivotal role in creating more effective medication for companion diagnostics. The extensive data acquired from heterogeneous genetic profiling has facilitated the ubiquitous use of AI. For instance, Deep Genomics, a start-up in Toronto, leverages artificial intelligence to discover superior treatments for genetic diseases and expedite their trial process. The aim is to use deep learning to probe the human genome to learn about disease causes and develop and evaluate chemical compounds that could potentially serve as cures. Through a computer simulation, deep learning enables scientists to run tests on billions of chemical combinations to identify potential promising formulations that could be turned into life-saving medicines globally.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report

Which Regions Are Becoming Hubs for Companion Diagnostics Market Innovation?
North America was the largest region in the companion diagnostics market in 2024. The regions covered in the companion diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Companion Diagnostics Market?
2. What is the CAGR expected in the Companion Diagnostics Market?
3. What Are the Key Innovations Transforming the Companion Diagnostics Industry?
4. Which Region Is Leading the Companion Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.